Skip to main content

Articles

Join WhatsApp Channel 

Regulatory Affairs Courses
  • DRUG DESIGNING : A REVIEW

    ABOUT AUTHOR:
    Muhammed Mujahed
    Master’s of Science in Biotechnology.
    SRTM University.
    mujubiotech2011@rediffmail.com

    INTRODUCTION:
    Drug design is an integrated developing discipline which portends an era of ‘tailored drug’. It involves the study of effects of biologically active compounds on the basis of molecular interactions in terms of molecular structure or its physico-chemical properties involved. It studies the processes by which the drug produce their effects, how they react with the protoplasm to elicit a particular pharmacological effect or response how they are modified or detoxified, metabolized or eliminated by the organism.

    Disposition of drugs in individual region of biosystems is one of the main factors determining the place , mode and intensity of their action . The biological activity may be “positive” as in drug design or “negative” as in toxicology. Thus drug design involves either total innovation of lead  or an optimization of already available lead. These concepts are the building stones up on which the edifice of drug design is built up.

    The drug is most commonly an organicsmall  molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense, drug design involves the design of small molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it. Drug design frequently but not necessarily relies on computer modeling techniques. This type of modeling is often referred to as computer-aided drug design. Finally, drug design that relies on the knowledge of the three-dimensional structure of the biomolecular target is known as structure-based drug design.

  • PRIMARY AMOEBIC MENINGOENCEPHALITIS

    ABOUT AUTHOR:
    Akshay Rajgaria
    Kanak Manjari Institute of Pharmaceutical Sciences
    Rourkela, Orissa
    akshaykrish2007@gmail.com

    ABSTRACT:
    Primary amoebic meningoencephalitis (PAM) caused by free-living amoebae Naegleria fowleri is a rare and fatal condition.

  • FORMULATION AND IN-VITRO EVALUATION OF BUCCOADHESIVE TABLETS OF AN ANTIHYPERTENSIVE DRUG: ENALAPRIL MALEATE

    About Authors:
    DILIP KUMAR
    Department of Pharmaceutics,
    Rajiv Academy for Pharmacy, Mathura-286001, Uttar Pradesh, India

    kumardilip.pharma@gmail.com

    ABSTRACT:
    The aim of the present study was to prepare and evaluate buccal tablet comprising a drug-containing buccoadhesive layer and a drug-free backing layer, by the direct compression method. The mucoadhesive layer was composed of a mixture of drug, hydroxypropylmethylcellulose (HPMC K4M), Carbopol 934P (CP), Sodium carboxy methyl cellulose (NaCMC), and the backing layer was made of ethyl cellulose. Enalapril maleate is an ace -inhibitor was formulated onto buccoadhesive tablets to overcome the limitations in the currently available dosage forms and routes of administration which in sequence will increase patient’s compliance. Formulations (F1-F9) were developed and subjected to various evaluation parameters. All tablets were acceptable with regard to thickness, weight variation, hardness, and drug content. Maximum bioadhesive force was observed in tablets formulated using CP-NaCMC as a bioadhesive polymer (F4-F6). Formulation F6 showed maximum permeation of 91.98 % ± 0.58 in 8hr. Formulation F3 showed maximum swelling index of 2.99 ± 0.01 after 8hr. The mucoadhesive force and residence time of the optimized batch F6 are 0.14 N ± 0.01 and 9.10 hrs ± 1.15 respectively. The results indicate that suitable buccoadhesive tablets with desired properties could be prepared.

  • FORMULATION, DEVELOPMENT AND OPTIMIZATION OF FAST DISPERSIBLE ORAL FILMS OF DOMPERIDONE MALEATE

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Krupa Mehta, Nitu Changoiwala, Sanjay C. Modi, Dr. Mukesh C. Gohel, Dr. Rajesh K. Parikh
    L. M. College of Pharmacy, Navrangpura,
    Ahmedabad, Gujarat-380009, India

    ABSTRACT:
    Objective:
    To Formulate, Develop and Optimize fast dispersible oral films of Domperidone maleate.
    Materials and Methods:
    Fast dispersible films of Domperidone maleate were prepared using solvent casting method. Films were formulated using Hydroxy Propyl Methyl Cellulose (HPMC-E5) as a film forming agent, PEG-400 as a plasticizer. A 32 full factorial design was applied systematically to optimize the drug release and folding endurance. The concentration of HPMC-E5 (X1) and concentration of PEG-400 (X2) were selected as independent variables.
      The Percentage Drug Release in 5 minutes (Y1) and Folding endurance (Y2) were selected as dependent variables. The prepared films were evaluated for Thickness, Folding endurance, Tensile Strength, Disintegration time, In vitro drug release and Drug content uniformity.  DSC studies were conducted for drug-excipient interactions.
    Results: Films prepared were found to be of good quality fulfilling all the requirements. Regression analysis and numerical optimization were performed to identify the best formulation. Formulations F10 prepared with 2.7% HPMC-E5 and 20% PEG-400 was found to be the best formulation with 96% Drug release in 5 minutes and folding endurance 24.
    Discussion: X1 and X2 significantly affected the Percentage Drug Release in 5 minutes (Y1) and Folding endurance (Y2). Percentage Drug Release decreased as the concentration of HPMC-E5 and PEG-400 increased. Folding endurance increased as the concentration of HPMC-E5 and PEG-400 increased.
    Conclusions: Fast dispersible films of Domperidone maleate were successfully formulated by Solvent casting technique with immediate onset of action & improved patient compliance.

  • GREENER ITINERARY TO THWART PHARMACY - EFFLUENCE

    ABOUT AUTHOR:
    Raaz K Maheshwari
    Department of Chemistry, SBRM PG Govt College,
    Nagaur, Rajasthan
    drraazgreenchemacs@gmail.com

    { DOWNLOAD AS PDF }

    ABSTRACT
    The use of PPCPs is on the rise on the globe. PPCPs enter into the environment through individual human activity and as residues from manufacturing, agribusiness, veterinary use, and hospital and community use. Individuals may add PPCPs to the environment through waste excretion and bathing as well as by directly disposing of unused medications to septic tanks, sewers, or trash. Because PPCPs tend to dissolve relatively easily and don’t evaporate at normal temperatures, they often end up in soil and water bodies. Some PPCPs are broken down or processed easily by a human or animal body and/or degrade quickly in the environment. However, others do not break down or degrade easily. The likelihood or ease with which an individual substance will break down depends on its chemical makeup and the metabolic pathway of the compound. Varying concentrations of drugs found in water sources can have ill effect on the aquatic life and human health. For pharmaceutical pollution, the solution calls upon all health care sectors to participate in preventing pharmaceutical pollution. Green Pharmacy aims at zero pharmaceutical waste in our environment. It offers an opportunity for social action that will greatly benefit our environment at all levels of our society. It encourages health providers and clients to focus on healthy lifestyle and prevention to ensure their well-being through regular wellness practices. It provides education and opportunity for everyone involved with the life cycle of medicine to participate in reducing pharmaceutical pollution. With relatively simple yet firm commitments to change our habits, becoming stewards of medicine rather than consumers of medicine we effectively become part of the solution. This review paper delineates about the powerful approaches of green pharmacy that provides comprehensive solution to pharmaceutical pollution affecting much of well being on globe. Research to date points to the ubiquity of PPCPs in aquatic environments. Existing wastewater treatment facilities are inadequate and aren’t designed to remove them from the waste stream. Our current system of quantifying their toxicological effects is inadequate. Now is the time to prevent further harm to living organisms and the environment.

  • AN OVERVIEW ON PULSATILE DRUG DELIVERY SYSTEM

    ABOUT AUTHORS:
    Edukondalu.Vanka*, M. Jhansi Rani, A.M.Sudhakar Babu, P.Venkatesawara Rao
    Department Of Pharmaceutics,
    A.M. Reddy Memorial College of Pharmacy,
    Narasaraopet, Guntur (district), Andhra Pradesh
    7yedu7@gmail.com

    { DOWNLOAD AS PDF }

    ABSTRACT:
    Novel Oral Drug Delivery technologies have emerged and expanded into different drug delivery System. Among them Pulsatile Drug Delivery Systems are gaining a lot of interest as they deliver the drug at the right place at the right time and in the right amount, thus providing spatial and temporal delivery and increasing patient compliance. The drug delivery is designed according to the circadian rhythm of body. System is suit for the drugs which shows high first pass effect. A pulse has to be designed in such a way that a complete and rapid drug release is achieved after the lag time. Various systems like  Time controlled pulsatile release systems, Stimuli-induced pulsatile release system, Externally regulated pulsatile release system, Multiparticulate regulated pulsatile release system have been dealt with in the article. These delivery occurs at predetermined lag time. These systems are beneficial for the drugs having chronopharmacological behavior where night time dosing is required, such as anti-arhythmic and anti-asthmatic.

  • ACUTE CORONARY SYNDROME(ACS)-DETAILS REVIEW

    ABOUT AUTHOR:
    Amitava Sinharay
    B.Pharm
    India
    a.amitava.s@gmail.com

  • SUSTAINED OPHTHALMIC DELIVERY OF MOXIFLOXACIN HYDROCHLORIDE AND KETOROLAC TROMETHAMINE FROM AN ION ACTIVATED IN-SITU GELLING SYSTEM

    ABOUT AUTHOR:
    Arya K.R.
    Department of Pharmaceutics, Regional Institute of Medical Sciences and Research,
    MG University, Kottayam
    aryajithu@yahoo.com

  • DRUG EXCIPIENT COMPATIBILITY STUDIES USING THERMAL METHODS

    ABOUT AUTHORS:
    Sandeep Kumar Patro*, M.Jhansi, Dr.A.M.S.Sudhakar Babu, Sk.Asief, P.Ramesh Babu
    A.M.Reddy memorial college of pharmacy, Narasaraopet.
    Sandeepkumarpatro2@gmail.com

    ABSTRACT
    Study of drug - excipient compatibility is an important process in development stage of dosage forms. Incompatibility between drugs and excipients alter drug stability and bioavailability &there by affect their safety and efficacy. Dosage form is a pharmaceutical drug delivery system, which is a combination of drug(s) and non-drug  components called as excipients. Drug is a chemical substance obtained from either natural, synthetic or semi synthetic source, which is used for the treatment, curing, prevention  or mitigation of a disease or disorder in human beings or animals Excipients are nondrug components which are serve specific purposes like shape, stability, solubility, elegance, palatability etc. of a dosage form. These are also called as adjuvants, additives or pharmaceutical aids. The evaluation of drug-excipient compatibility is therefore an essential aspect of any preformulation study. To evaluate the drug- excipient compatibility different techniques such as  Thermal analysis, Differential scanning  calorimetric (DSC) study, Infra red spectrophotometric study (IR), Isothermal stress testing (IST), High performance liquid chromatography (HPLC),Thin layer chromatography (TLC), Solution calorimetry  were adopted.

  • FREGOLI SYNDROME

    ABOUT AUTHOR:
    Jyotirmoyee Patnaik
    Kanak Manjari Institute of pharmaceutical Sciences
    Rourkela, Orissa
    patnaik.jyotirmoyee@gmail.com

    ABSTRACT:
    During the past 80 years, delusional misidentification syndromes (DMS), especially the Fregoli a syndromes, have posed challenges to mental health professionals due to a lack of comprehensive understanding of the syndromes and a lack of effective treatment. During the past two decades, neurophysiological and neuroimaging studies have pointed to the presence of identifiable brain lesions, especially in the right front parietal and adjacent regions, in a considerable proportion of patients with DMS. Prior to the advent of such studies, DMS phenomena were explained predominantly from the psychodynamic point of view. Deficits in working memory due to abnormal brain function are considered to play causative roles in DMS.

Subscribe to Articles